Moreover, another recent report presented evidence that C/EBPα promotes NASH and hepatocellular carcinoma via activation of hyaluronan mediated motility receptor (HMMR) by binding to its promoter.27 The gene discussed is HMMR; the disease is hepatocellular carcinoma.